Table 1.
Characteristics of the Study Population.
| Unvaccinated | Vaccinated | p-Value | |
|---|---|---|---|
| Total Number of Subjects | 59 | 28 | N/A |
| Days of Sample Storage at 4 °C Prior to Freezing at −80 °C | 5 (3–5) | 5 (3–6) | 0.7615 |
| Years of Age | 40.1 (30.1–49.0) | 48.2 (35.3–69.8) | 0.0063 |
| BMI | 31.8 (28.5–37.4) | 33.6 (30.0–39.6) | 0.2950 |
| Sex | |||
| Female | 30 (50.9) | 14 (50.0) | >0.9999 |
| Male | 29 (49.2) | 14 (50.0) | |
| Race | |||
| Black or African American | 7 (11.9) | 4 (14.3) | 0.3481 |
| Caucasian/White | 52 (88.1) | 23 (82.1) | |
| Asian | 0 (0.0) | 1 (3.6) | |
| Ethnicity | |||
| Hispanic or Latino | 15 (25.4) | 6 (21.4) | 0.7922 |
| Not Hispanic or Latino | 44 (74.6) | 22 (78.6) | |
| Number of Comorbidities | |||
| 0 | 3 (8.3) | 2 (8.3) | 0.3477 |
| 1 | 18 (50.0) | 6 (25.0) | |
| 2 | 7 (19.4) | 8 (33.3) | |
| 3 | 5 (13.9) | 6 (25.0) | |
| 4–5 | 3 (8.3) | 2 (8.3) | |
| Reported Symptom Development After Sample Collection | 14 (23.7) | 7 (25.0) | >0.9999 |